Chen, Delin
Chu, Bo
Yang, Xin
Liu, Zhaoqi
Jin, Ying
Kon, Ning
Rabadan, Raul http://orcid.org/0000-0001-7946-9255
Jiang, Xuejun http://orcid.org/0000-0002-8670-3828
Stockwell, Brent R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5R01CA216884, 5R01CA085533, 5R01CA254970, 5RO1CA224272)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 16 April 2020
Accepted: 21 May 2021
First Online: 15 June 2021
Competing interests
: B.R.S. holds equity in and serves as a consultant to Inzen Therapeutics and is an inventor on patents and applications related to ferroptosis. The other authors declare no competing interests.